Taro Pharmaceutical Industries Ltd.
TARO
TARO was delisted on the 21st of June, 2024.
96 hedge funds and large institutions have $715M invested in Taro Pharmaceutical Industries Ltd. in 2015 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 36 increasing their positions, 33 reducing their positions, and 8 closing their positions.
100% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 8
84% more call options, than puts
Call options by funds: $12.8M | Put options by funds: $6.97M
8% more funds holding
Funds holding: 89 → 96 (+7)
9% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 33
7% less capital invested
Capital invested by funds: $771M → $715M (-$56.7M)
23% less funds holding in top 10
Funds holding in top 10: 13 → 10 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MICM
Matthews International Capital Management
San Francisco,
California
|
+$76.7M |
| 2 |
GC
GW Capital
Bellevue,
Washington
|
+$5.07M |
| 3 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$4.62M |
| 4 |
Millennium Management
New York
|
+$3.53M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.49M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$39.9M |
| 2 |
AIM
Assured Investment Management
New York
|
-$18.9M |
| 3 |
PA
Perceptive Advisors
New York
|
-$18.5M |
| 4 |
RCM
Raging Capital Management
Rocky Hill,
New Jersey
|
-$14.1M |
| 5 |
ICM
ISZO Capital Management
New York
|
-$13M |
TARO Hedge Fund Activity: Q1 2015 in Review
96 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q1 2015, worth a combined $715M — down 7.3% from $771M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new TARO positions and 8 closed out — a net gain of 8 holders — while 36 added to existing stakes and 33 trimmed.
The largest buyer was Matthews International Capital Management, adding an estimated $76.7M. The largest seller was RTW Investments, cutting an estimated $39.9M.
- 96 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q1 2015, up from 89 in Q4 2014.
- Funds reported $715M of Taro Pharmaceutical Industries Ltd. stock for Q1 2015, down 7.3% quarter-over-quarter.
- 16 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q1 2015 and 8 closed out, a net change of +8 holders.
- The largest Taro Pharmaceutical Industries Ltd. buyer in Q1 2015 was Matthews International Capital Management, an estimated $76.7M added.
- The largest Taro Pharmaceutical Industries Ltd. seller in Q1 2015 was RTW Investments, an estimated $39.9M sold.
Based on aggregated 13F filings for Q1 2015.